Neogen Co. (NASDAQ:NEOG) VP Edward Bradley sold 7,000 shares of the stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $59.60, for a total value of $417,200.00. Following the sale, the vice president now owns 12,735 shares of the company’s stock, valued at approximately $759,006. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Edward Bradley also recently made the following trade(s):
- On Friday, February 16th, Edward Bradley sold 4,223 shares of Neogen stock. The shares were sold at an average price of $60.00, for a total value of $253,380.00.
- On Friday, January 26th, Edward Bradley sold 100 shares of Neogen stock. The shares were sold at an average price of $60.00, for a total value of $6,000.00.
- On Tuesday, January 30th, Edward Bradley sold 11,725 shares of Neogen stock. The shares were sold at an average price of $60.29, for a total value of $706,900.25.
Shares of Neogen Co. (NASDAQ:NEOG) traded up $1.16 during trading hours on Thursday, hitting $60.11. The company had a trading volume of 200,500 shares, compared to its average volume of 177,052. Neogen Co. has a twelve month low of $44.63 and a twelve month high of $64.42. The stock has a market capitalization of $3,037.26, a price-to-earnings ratio of 58.66, a price-to-earnings-growth ratio of 3.65 and a beta of 1.46.
Neogen (NASDAQ:NEOG) last announced its quarterly earnings data on Wednesday, January 3rd. The company reported $0.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.26 by $0.07. Neogen had a return on equity of 10.72% and a net margin of 13.47%. The business had revenue of $101.80 million during the quarter, compared to analyst estimates of $102.46 million. During the same period last year, the company earned $0.29 earnings per share. Neogen’s quarterly revenue was up 12.2% compared to the same quarter last year. equities analysts anticipate that Neogen Co. will post 1.08 EPS for the current year.
A number of analysts have recently issued reports on the company. BidaskClub lowered Neogen from a “buy” rating to a “hold” rating in a report on Thursday, January 11th. Stephens restated a “hold” rating and issued a $62.00 target price on shares of Neogen in a report on Wednesday, January 10th. Zacks Investment Research lowered Neogen from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 15th. Craig Hallum increased their target price on Neogen from $46.50 to $60.00 and gave the company a “hold” rating in a report on Thursday, December 7th. Finally, Roth Capital assumed coverage on Neogen in a report on Tuesday, December 5th. They issued a “neutral” rating and a $61.50 target price for the company. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Neogen presently has a consensus rating of “Hold” and an average price target of $63.25.
Several large investors have recently made changes to their positions in NEOG. Catalyst Capital Advisors LLC purchased a new stake in shares of Neogen during the fourth quarter worth $156,000. Bell Bank acquired a new position in Neogen during the third quarter worth $201,000. Parametrica Management Ltd acquired a new position in Neogen during the third quarter worth $202,000. Arcadia Investment Management Corp MI acquired a new position in Neogen during the third quarter worth $230,000. Finally, Stone Ridge Asset Management LLC acquired a new position in Neogen during the fourth quarter worth $241,000. Institutional investors and hedge funds own 66.13% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another publication, it was stolen and republished in violation of United States and international trademark & copyright laws. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/22/insider-selling-neogen-co-neog-vp-sells-7000-shares-of-stock.html.
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.